Trillium Ag
Paul Olivier is the Chief Scientist at Trillium AG, a company focusing on the development of innovative technologies to enhance farm productivity. With previous experience at Halo-Bio RNAi Therapeutics, Inc. and Targeted Growth, Paul has a strong background in agricultural research. Previously, Paul worked as a Postdoc at Fred Hutch Cancer Research Center after completing a B.Sc. and PhD in Medical Genetics and Biochemistry at the University of Toronto - University of St. Michael's College.
This person is not in any teams
Trillium Ag
Trillium Ag is developing a portfolio of RNAi-based biologicals to improve crop protection, health and yield. Our product pipeline is based on the breakthrough RNAi trigger (MV-RNA, US Patent 9,200,276) and nanoparticles for transient or stable trait activation.